Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 698313, 12 pages
http://dx.doi.org/10.1155/2014/698313
Review Article

Interleukin 6 and Rheumatoid Arthritis

1Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
2Department of Clinical Application of Biologics, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita City, Osaka 565-0871, Japan
3Department of Immunopathology, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan

Received 20 September 2013; Revised 19 November 2013; Accepted 11 December 2013; Published 12 January 2014

Academic Editor: Juan-Manuel Anaya

Copyright © 2014 Yuji Yoshida and Toshio Tanaka. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [61 citations]

The following is the list of published articles that have cited the current article.

  • Justin S. Bickford, Narjis F. Ali, Jerelyn A. Nick, Musab Al-Yahia, Dawn E. Beachy, Sylvain Doré, Harry S. Nick, and Michael F. Waters, “Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism,” Brain Research, 2014. View at Publisher · View at Google Scholar
  • Christina Mary Mariaselvam, Masayuki Aoki, Sofiane Salah, Wahid Boukouaci, Hélène Moins-Teisserenc, Dominique Charron, Rajagopal Krishnamoorthy, Ryad Tamouza, and Vir Singh Negi, “Cytokine expression and cytokine-based T cell profiling in South Indian Rheumatoid Arthritis,” Immunobiology, 2014. View at Publisher · View at Google Scholar
  • Wei Kou, Rong Sun, Ping Wei, Hong-Bing Yao, Cheng Zhang, Xin-Ye Tang, and Su-Ling Hong, “Andrographolide Suppresses IL-6/Stat3 Signaling in Peripheral Blood Mononuclear Cells from Patients with Chronic Rhinosinusitis with Nasal Polyps,” Inflammation, 2014. View at Publisher · View at Google Scholar
  • Luca Semerano, Allan Thiolat, Emeline Minichiello, Gaëlle Clavel, Natacha Bessis, and Marie-Christophe Boissier, “Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs,” Expert Opinion on Investigational Drugs, pp. 1–21, 2014. View at Publisher · View at Google Scholar
  • Kathleen Chang, So Min Yang, Seong Heon Kim, Kyoung Hee Han, Se Jin Park, and Jae Il Shin, “Smoking and Rheumatoid Arthritis,” International Journal Of Molecular Sciences, vol. 15, no. 12, pp. 22279–22295, 2014. View at Publisher · View at Google Scholar
  • B. Karshikoff, M. Lekander, A. Soop, F. Lindstedt, M. Ingvar, E. Kosek, C. Olgart Höglund, and J. Axelsson, “Modality and sex differences in pain sensitivity during human endotoxemia,” Brain, Behavior, and Immunity, 2014. View at Publisher · View at Google Scholar
  • M. Pihut, M. Szuta, E. Ferendiuk, and D. Zeńczak-Więckiewicz, “Differential Diagnostics of Pain in the Course of Trigeminal Neuralgia and Temporomandibular Joint Dysfunction,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Chun Tang, Yun Li, Xiaojun Lin, Jinghua Ye, Weinian Li, Zhixiang He, Fangfei Li, and Xiaoyan Cai, “Hypomethylation of interleukin 6 correlates with renal involvement in systemic lupus erythematosus,” Central European Journal of Immunology, vol. 39, no. 2, pp. 203–208, 2014. View at Publisher · View at Google Scholar
  • Michael E. Weinblatt, Philip Mease, Eduardo Mysler, Tsutomu Takeuchi, Edit Drescher, Alberto Berman, Jun Xing, Moshe Zilberstein, Subhashis Banerjee, and Paul Emery, “The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra,” Arthritis & Rheumatology, vol. 67, no. 10, pp. 2591–2600, 2015. View at Publisher · View at Google Scholar
  • Qing Liu, Xiu-Zhen Zhu, Rui-Bing Feng, Zhong Liu, Gui-Yang Wang, Xi-Feng Guan, Guo-min Ou, Yao-Lan Li, Ying Wang, Man-Mei Li, and Wen-Cai Ye, “Crude triterpenoid saponins from Anemone flaccida (Di Wu) exert anti-arthritic effects on type II collagen-induced arthritis in rats,” Chinese Medicine, vol. 10, no. 1, 2015. View at Publisher · View at Google Scholar
  • Maarten Van Roy, Cedric Ververken, Els Beirnaert, Sven Hoefman, Joost Kolkman, Michel Vierboom, Elia Breedveld, Bert ‘t Hart, Sofie Poelmans, Lieselot Bontinck, Alex Hemeryck, Sandy Jacobs, Judith Baumeister, and Hans Ulrichts, “The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis,” Arthritis Research & Therapy, vol. 17, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yuji Yoshida, Atsushi Ogata, Sujin Kang, Kousuke Ebina, Kenrin Shi, Satoshi Nojima, Tetsuya Kimura, Daisuke Ito, Keiko Morimoto, Masayuki Nishide, Takashi Hosokawa, Toru Hirano, Yoshihito Shima, Masashi Narazaki, Hideki Tsuboi, Yukihiko Saeki, Tetsuya Tomita, Toshio Tanaka, and Atsushi Kumanogoh, “Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications,” Arthritis & Rheumatology, vol. 67, no. 6, pp. 1481–1490, 2015. View at Publisher · View at Google Scholar
  • Mads Almose Røpke, “Clinical Validation,” Biomarker Validation, pp. 207–230, 2015. View at Publisher · View at Google Scholar
  • Ida Waern, Iulia Karlsson, Gunnar Pejler, and Sara Wernersson, “IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis,” Immunity, Inflammation and Disease, 2015. View at Publisher · View at Google Scholar
  • Cindy Mourgues, Cecile Henquell, Zuzana Tatar, Bruno Pereira, Cinthya Nourisson, Anne Tournadre, Martin Soubrier, and Marion Couderc, “Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis,” Joint Bone Spine, 2015. View at Publisher · View at Google Scholar
  • Masao Hirota, Ikuo Murakami, Yuichi Ishikawa, Tomoki Suzuki, Shun-ichiro Sumida, Shigeru Ibaragi, Hayato Kasai, Naoto Horai, Daniel W. Drolet, Shashi Gupta, Nebojsa Janjic, and Daniel J. Schneider, “Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys,” Nucleic Acid Therapeutics, 2015. View at Publisher · View at Google Scholar
  • Shivaprasad H. Venkatesha, Steven Dudics, Bodhraj Acharya, and Kamal D. Moudgil, “Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy,” International Journal Of Molecular Sciences, vol. 16, no. 1, pp. 887–906, 2015. View at Publisher · View at Google Scholar
  • Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Giacomo Maria Guidelli, Enrico Selvi, Maurizio Acampa, and Franco Laghi-Pasini, “Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date,” Drug Design, Development and Therapy, vol. 10, pp. 3083–3097, 2016. View at Publisher · View at Google Scholar
  • Ping Jia, Gang Chen, Wen-Yi Qin, Yu Zhong, Juan Yang, and Xiao-Feng Rong, “Xitong Wan attenuates inflammation development through inhibiting the activation of nuclear factor-κB in rats with adjuvant-induced arthritis,” Journal of Ethnopharmacology, 2016. View at Publisher · View at Google Scholar
  • Atif Zafar, Abdul Qayyum Khan, Somaiya Mateen, Shagufta Moin, and Swaleha Zubair, “Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis,” Clinica Chimica Acta, vol. 455, pp. 161–171, 2016. View at Publisher · View at Google Scholar
  • Rashi Verma, Monika Yadav, Dibyabhaba Pradhan, Rajabrata Bhuyan, Shweta Aggarwal, Arnab Nayek, and Arun Kumar Jain, “ Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases ,” Journal of Receptors and Signal Transduction, pp. 1–16, 2016. View at Publisher · View at Google Scholar
  • Paola Bonaventura, Aline Lamboux, Francis Albarede, and Pierre Miossec, “A Feedback Loop between Inflammation and Zn Uptake,” Plos One, vol. 11, no. 2, 2016. View at Publisher · View at Google Scholar
  • Khalda Amr, Rehab El-Awady, and Hala Raslan, “Assessment of the −174G/C (Rs1800795) and −572G/C (rs1800796) Interleukin 6 gene polymorphisms in Egyptian patients with rheumatoid arthritis,” Macedonian Journal of Medical Sciences, vol. 4, no. 4, pp. 574–577, 2016. View at Publisher · View at Google Scholar
  • Jun Bon Koo, and Joong-Soo Han, “Cigarette smoke extract-induced interleukin-6 expression is regulated by phospholipase D1 in human bronchial epithelial cells,” The Journal of Toxicological Sciences, vol. 41, no. 1, pp. 77–89, 2016. View at Publisher · View at Google Scholar
  • Santimov, and Grom, “Other Biological Therapies for Pediatric Rheumatic Diseases,” Handbook of Systemic Autoimmune Diseases, vol. 11, pp. 503–525, 2016. View at Publisher · View at Google Scholar
  • Somaiya Mateen, Shagufta Moin, Sumayya Shahzad, and Abdul Qayyum Khan, “Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species,” Plos One, vol. 12, no. 6, pp. e0178879, 2017. View at Publisher · View at Google Scholar
  • Qing Liu, Xu-Hui Xiao, Liu-Bing Hu, Hui-Yang Jie, Ying Wang, Wen-Cai Ye, Man-Mei Li, and Zhong Liu, “Anhuienoside C Ameliorates Collagen-Induced Arthritis through Inhibition of MAPK and NF-κB Signaling Pathways,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Cindy Mourgues, Cécile Henquell, Zuzana Tatar, Bruno Pereira, Cynthia Nourisson, Anne Tournadre, Martin Soubrier, and Marion Couderc, “Surveillance de la charge virale des virus Epstein-Barr (EBV), cytomégalovirus (CMV) et de la varicelle (VZV) chez les patients traités par tocilizumab pour la polyarthrite rhumatoïde,” Revue du Rhumatisme, 2017. View at Publisher · View at Google Scholar
  • Eleftherios Pelechas, Paraskevi V. Voulgari, and Alexandros A. Drosos, “Sirukumab: a promising therapy for rheumatoid arthritis,” Expert Opinion on Biological Therapy, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Morteza Ghandadi, and Amirhossein Sahebkar, “Curcumin: An effective inhibitor of interleukin-6,” Current Pharmaceutical Design, vol. 23, no. 6, pp. 921–931, 2017. View at Publisher · View at Google Scholar
  • Monika Østensen, “The use of biologics in pregnant patients with rheumatic disease,” Expert Review of Clinical Pharmacology, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Justin B. Schaal, Dat Q. Tran, Akshay Subramanian, Reshma Patel, Teresina Laragione, Kevin D. Roberts, Katie Trinh, Prasad Tongaonkar, Patti A. Tran, Dmitriy Minond, Gregg B. Fields, Paul Beringer, André J. Ouellette, Percio S. Gulko, and Michael E. Selsted, “Suppression and resolution of autoimmune arthritis by rhesus θ-defensin-1, an immunomodulatory macrocyclic peptide,” Plos One, vol. 12, no. 11, pp. e0187868, 2017. View at Publisher · View at Google Scholar
  • Meiyan Song, Mengshi Tang, Jinwei Chen, Jing Tian, Jinfeng Du, Ni Mao, Suqing Xu, Jiesheng Gao, Guanghui Ling, Fen Li, Xi Xie, Yiming Liu, and Shu Li, “Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis,” Journal of Central South University (Medical Sciences), vol. 42, no. 10, pp. 1174–1177, 2017. View at Publisher · View at Google Scholar
  • Adam Wells, Debra J. Romberger, Geoffrey M. Thiele, Todd A. Wyatt, Elizabeth Staab, Art J. Heires, Lynell W. Klassen, Michael J. Duryee, Ted R. Mikuls, Anand Dusad, William W. West, Dong Wang, and Jill A. Poole, “Systemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic Dust,” Journal of Interferon & Cytokine Research, vol. 37, no. 1, pp. 9–19, 2017. View at Publisher · View at Google Scholar
  • Roy Fleischmann, Janet van Adelsberg, Yong Lin, Geraldo da Rocha Castelar-Pinheiro, Jan Brzezicki, Pawel Hrycaj, Neil M. H. Graham, Hubert van Hoogstraten, Deborah Bauer, and Gerd R. Burmester, “Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors,” Arthritis & Rheumatology, vol. 69, no. 2, pp. 277–290, 2017. View at Publisher · View at Google Scholar
  • Yanyi Li, and Weiting Zhang, “IL-6: the next key target for rheumatoid arthritis after TNF-α,” Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology, vol. 33, no. 1, pp. 36–43, 2017. View at Publisher · View at Google Scholar
  • Kazuhiko Kotani, Michiaki Miyamoto, and Hitoshi Ando, “The effect of treatments for rheumatoid arthritis on endothelial dysfunction evaluated by flow-mediated vasodilation in patients with rheumatoid arthritis,” Current Vascular Pharmacology, vol. 15, no. 1, pp. 10–18, 2017. View at Publisher · View at Google Scholar
  • Ali H. Ad'hiah, Aseel S. Mahmood, Abdul-Kareem A. Al-kazaz, and Khadier K. Mayouf, “Gene expression and six single nucleotide polymorphisms of interleukin-6 in rheumatoid arthritis: A case-control study in Iraqi patients,” Alexandria Journal of Medicine, 2018. View at Publisher · View at Google Scholar
  • Huan Liu, Shu-Ping Wei, Li-Qin Zhi, Li-Ping Liu, Tuan-Ping Cao, Su-Zhi Wang, Qing-Ping Chen, and Dan Liu, “ Synovial GATA1 mediates rheumatoid arthritis progression via transcriptional activation of NOS2 signaling ,” Microbiology and Immunology, 2018. View at Publisher · View at Google Scholar
  • Simon Wing-Fai Mok, Betty Yuen-Kwan Law, Vincent Kam-Wai Wong, and Liang Liu, “Immunotherapeutic Approaches of Rheumatoid Arthritis and the Implication on Novel Interventions for Refractoriness,” Immunoregulatory Aspects of Immunotherapy, 2018. View at Publisher · View at Google Scholar
  • Valeria Graceffa, Claire Vinatier, Jerome Guicheux, Christopher H. Evans, Martin Stoddart, Mauro Alini, and Dimitrios I. Zeugolis, “State of art and limitations in genetic engineering to induce stable chondrogenic phenotype,” Biotechnology Advances, 2018. View at Publisher · View at Google Scholar
  • Tiago Silva da Fonseca, Guilherme F. Silva, Juliane M. Guerreiro-Tanomaru, Mateus Machado Delfino, Estela Sasso-Cerri, Mário Tanomaru-Filho, and Paulo Sérgio Cerri, “Biodentine and MTA modulate immunoinflammatory response favoring bone formation in sealing of furcation perforations in rat molars,” Clinical Oral Investigations, 2018. View at Publisher · View at Google Scholar
  • S. Jayashree, K. Nirekshana, Gunjan Guha, and Dipita Bhakta-Guha, “Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection,” Biomedicine & Pharmacotherapy, vol. 102, pp. 894–911, 2018. View at Publisher · View at Google Scholar
  • Doojin Kim, Sora Mun, Jiyeong Lee, Arum Park, AeEun Seok, Yeon-Tae Chun, and Hee-Gyoo Kang, “Proteomics analysis reveals differential pattern of widespread protein expression and novel role of histidine-rich glycoprotein and lipopolysaccharide-binding protein in rheumatoid arthritis,” International Journal of Biological Macromolecules, vol. 109, pp. 704–710, 2018. View at Publisher · View at Google Scholar
  • Michael Lyman, Vincent Lieuw, Robyn Richardson, Anjuli Timmer, Christine Stewart, Steve Granger, Richard Woods, Michela Silacci, Dragan Grabulovski, and Roland Newman, “A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases,” Journal of Biological Chemistry, vol. 293, no. 24, pp. 9326–9334, 2018. View at Publisher · View at Google Scholar
  • Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Masayoshi Harigai, Toshikazu Nakano, Koshiro Akagi, Yoshifumi Ukyo, and Benjamin Hsu, “Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 study,” Modern Rheumatology, pp. 1–9, 2018. View at Publisher · View at Google Scholar
  • Joseph M. Carrington, and Jill A. Poole, “The Effect of Inhalant Organic Dust on Bone Health,” Current Allergy and Asthma Reports, vol. 18, no. 3, 2018. View at Publisher · View at Google Scholar
  • Nikos C. Apostolopoulos, and Nikos C. Apostolopoulos, “Literature Review,” Stretch Intensity and the Inflammatory Response: A Paradigm Shift, pp. 5–129, 2018. View at Publisher · View at Google Scholar
  • Diana Rocio Herrera-Aco, Omar Noel Medina-Campos, José Pedraza-Chaverri, Edda Sciutto-Conde, Gabriela Rosas-Salgado, and Gladis Fragoso-González, “Alpha-mangostin: Anti-inflammatory and antioxidant effects on established collagen-induced arthritis in DBA/1J mice,” Food and Chemical Toxicology, 2018. View at Publisher · View at Google Scholar
  • J. Wielińska, M. Dratwa, J. Świerkot, L. Korman, M. Iwaszko, B. Wysoczańska, and K. Bogunia-Kubik, “Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis,” Hla, vol. 92, pp. 38–41, 2018. View at Publisher · View at Google Scholar
  • Paul Emery, Juan Rondon, Janie Parrino, Yong Lin, Claudia Pena-Rossi, Hubert van Hoogstraten, Neil M H Graham, Nancy Liu, Anne Paccaly, Richard Wu, and Alberto Spindler, “Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis,” Rheumatology, 2018. View at Publisher · View at Google Scholar
  • An Wei, Hao Feng, Xiao-Min Jia, Hua Tang, Yang-Ying Liao, and Bi-Rong Li, “Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease,” Biomedicine & Pharmacotherapy, vol. 107, pp. 1418–1425, 2018. View at Publisher · View at Google Scholar
  • Majid Khoshmirsafa, Farhad Seif, Nader Bagheri, Pezhman Beshkar, Mohammad Mousavi, and Hedayatollah Shirzad, “Correlation of interleukin 6 and transforming growth factor β1 with peripheral blood regulatory T cells in rheumatoid arthritis patients: A potential biomarker,” Central European Journal of Immunology, vol. 43, no. 3, pp. 281–288, 2018. View at Publisher · View at Google Scholar
  • Fabiola Atzeni, Alberto Batticciotto, Maurizio Benucci, Rossella Talotta, Sara Bongiovanni, and Piercarlo Sarzi-Puttini, “Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance,” Current Rheumatology Reviews, vol. 14, no. 2, pp. 131–139, 2018. View at Publisher · View at Google Scholar
  • Christine Xu, Yaming Su, Anne Paccaly, and Vanaja Kanamaluru, “Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis,” Clinical Pharmacokinetics, 2019. View at Publisher · View at Google Scholar
  • Parisa Zafari, Alireza Rafiei, Seyed‐Alireza Esmaeili, Mohammadreza Moonesi, and Mahdi Taghadosi, “Survivin a pivotal antiapoptotic protein in rheumatoid arthritis,” Journal of Cellular Physiology, 2019. View at Publisher · View at Google Scholar
  • Marjan Khazan, Soheila Nasiri, Seyed M. Riahi, Reza M. Robati, and Mehdi Hedayati, “Measurement of melatonin, indole‐dioxygenase, IL‐6, IL‐18, ferritin, CRP, and total homocysteine levels during herpes zoster,” Journal of Medical Virology, 2019. View at Publisher · View at Google Scholar
  • Talat Roome, Sabahat Aziz, Anam Razzak, Zara Aslam, Lubna, Khawar Saeed Jamali, Bushra Sikandar, Tehseen Fatima, Lubna Abidi, Muhammad Imran, Shaheen Faizi, and Muhammad Raza Shah, “Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: Novel suppressors of Toll-like receptors -2 and -4,” Biomedicine & Pharmacotherapy, vol. 112, pp. 108624, 2019. View at Publisher · View at Google Scholar
  • Elham Rajaei, Habib Haybar, Karim Mowla, and Zeinab D. Zayeri, “Metformin one in a Million Efficient Medicines for Rheumatoid Arthritis Complications: Inflammation, Osteoblastogenesis, Cardiovascular Disease, Malignancies,” Current Rheumatology Reviews, vol. 15, no. 2, pp. 116–122, 2019. View at Publisher · View at Google Scholar
  • Shyi-Jou Chen, Gu-Jiun Lin, Jing-Wun Chen, Kai-Chen Wang, Chiung-Hsi Tien, Chih-Fen Hu, Chia-Ning Chang, Wan-Fu Hsu, Hueng-Chuen Fan, and Huey-Kang Sytwu, “Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis,” International Journal of Molecular Sciences, vol. 20, no. 6, pp. 1332, 2019. View at Publisher · View at Google Scholar
  • Joana P. Miranda, Sérgio P. Camões, Maria M. Gaspar, Joana S. Rodrigues, Manuela Carvalheiro, Rita N. Bárcia, Pedro Cruz, Helder Cruz, Sandra Simões, and Jorge M. Santos, “The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis,” Frontiers in Immunology, vol. 10, 2019. View at Publisher · View at Google Scholar